Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9

Citation
M. Suganuma et al., Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9, CANCER RES, 59(1), 1999, pp. 44-47
Citations number
20
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
59
Issue
1
Year of publication
1999
Pages
44 - 47
Database
ISI
SICI code
0008-5472(19990101)59:1<44:SEO(GW>2.0.ZU;2-H
Abstract
The study on incorporation of [H-3](-)-epigallocatechin gallate (EGCG) into human lung cancer cell line PC-9 indicated that the [H-3]EGCG incorporatio n was significantly enhanced by (-)-epicatechin, an inert tea polyphenol wi thout a galloyl moiety, (-)-Epicatechin enhanced apoptosis, growth inhibiti on of PC-9 cells, and inhibition of tumor necrosis factor-alpha release fro m BALB/c-3T3 cells by EGCG and other tea polyphenols with a galloyl moiety in a dose-dependent manner. Moreover, the effects of EGCG on induction of a poptosis were also synergistically enhanced by other cancer-preventive agen ts, such as sulindac and tamoxifen, This paper reports significant evidence that whole green tea is a more reasonable mixture of tea polyphenols for c ancer prevention in humans than EGCG alone and that it is even more effecti ve when it is used in combination with other cancer preventives.